Short-term survival and safety of apatinib combined with oxaliplatin and S-1 in the conversion therapy of unresectable gastric cancer

被引：0
|
作者：
Zaisheng Ye
Yi Zeng
Shenghong Wei
Yi Wang
Zhitao Lin
Shu Chen
Zhiwei Wang
Shanshan Chen
Luchuan Chen
机构：
[1] Fujian Cancer Hospital & Fujian Medical University Cancer Hospital,Department of Gastrointestinal Surgical Oncology
[2] Fujian Cancer Hospital & Fujian Medical University Cancer Hospital,Department of Fujian Provincial Key Laboratory of Tumor Biotherapy
来源：
BMC Cancer | / 21卷
关键词：
Unresectable gastric cancer; Conversion therapy; Apatinib; Efficacy; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Short-term survival and safety of apatinib combined with oxaliplatin and S-1 in the conversion therapy of unresectable gastric cancer
    Ye, Zaisheng
    Zeng, Yi
    Wei, Shenghong
    Wang, Yi
    Lin, Zhitao
    Chen, Shu
    Wang, Zhiwei
    Chen, Shanshan
    Chen, Luchuan
    BMC CANCER, 2021, 21 (01)
  • [2] S-1 Combined With Apatinib and Trans-arterial Chemotherapy and Embolization for Conversion Therapy of Unresectable Locally Advanced Gastric Cancer
    Su Zhaoran
    Kang Min
    Shu Kuanshan
    Li Kunfeng
    Wang Guihe
    JOURNAL OF SURGICAL RESEARCH, 2022, 270 : 162 - 168
  • [3] Short term efficacy and safety of PD-1 inhibitor and apatinib plus S-1 and oxaliplatin as neoadjuvant chemotherapy for patients with locally advanced gastric cancer
    Tang, Yunchuan
    Dai, Li
    Wang, Zhiqin
    Zhang, Meifeng
    Xie, Haitao
    Yang, Yunshan
    Zhou, Yongjin
    Yan, Zhiqiang
    Wang, Haibin
    Yang, Hongxin
    Zhang, Lei
    He, Tong
    Chen, Jiaju
    Wang, Guanghai
    Jin, Xiangren
    Wang, Qian
    MEDICINE, 2024, 103 (46) : e40572
  • [4] Apatinib combined with S-1 as second-line therapy in advanced gastric cancer
    Qiu, Zhi-Yuan
    Qin, Rong
    Tian, Guang-Yu
    Zhang, Zhao
    Chen, Meifang
    He, Han
    Xi, Yan
    Wang, Yan
    MEDICINE, 2021, 100 (17) : E25630
  • [5] Efficacy of Conversion Surgery Following S-1 plus Cisplatin or Oxaliplatin Chemotherapy for Unresectable Gastric Cancer
    Fukuchi, Minoru
    Mochiki, Erito
    Ishiguro, Toru
    Ogura, Toshiro
    Sobajima, Jun
    Kumagai, Youichi
    Ishibashi, Keiichiro
    Ishida, Hideyuki
    ANTICANCER RESEARCH, 2017, 37 (03) : 1343 - 1347
  • [6] Neoadjuvant PD-1 inhibitor and apatinib combined with S-1 plus oxaliplatin for locally advanced gastric cancer patients: a multicentered, prospective, cohort study
    Xu, Chao
    Xie, Xiaoli
    Kang, Ning
    Jiang, Huiqing
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (07) : 4091 - 4099
  • [7] Neoadjuvant PD-1 inhibitor and apatinib combined with S-1 plus oxaliplatin for locally advanced gastric cancer patients: a multicentered, prospective, cohort study
    Chao Xu
    Xiaoli Xie
    Ning Kang
    Huiqing Jiang
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 4091 - 4099
  • [8] The efficacy and safety of apatinib combined with S-1 for advanced gastric cancer: A systematic review and meta-analysis
    Chen, Xing
    Wan, Lifu
    He, Yao
    Zhang, Qin
    Zheng, Xiaoyuan
    MEDICINE, 2024, 103 (21) : E38272
  • [9] Efficacy and prognosis analyses of apatinib combined with S-1 in third-line chemotherapy for advanced gastric cancer
    Wu, Qiuju
    Fu, Yingchun
    Wen, Wenlong
    Xi, Ting
    Zhao, Guangling
    JOURNAL OF BUON, 2020, 25 (02): : 987 - 994
  • [10] Neoadjuvant intraperitoneal and systemic paclitaxel combined with apatinib and S-1 chemotherapy for conversion therapy in gastric cancer patients with positive exfoliative cytology: a prospective study
    Ding, Ping'an
    Yang, Peigang
    Tian, Yuan
    Guo, Honghai
    Liu, Yang
    Zhang, Ze
    Zheng, Tao
    Tan, Bibo
    Zhang, Zhidong
    Wang, Dong
    Li, Yong
    Zhao, Qun
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 12 (04) : 1416 - 1427
12345